EUVIMEDEUVIMED entdecken
Kohortenstudie

Clinical efficacy of Xuebijing injection for the treatment of sepsis: A retrospective cohort study

Zhao-Tang Gong, Hong-Xin Yang, Ben-Ben Zhu, Huan-Huan Liu, Guleng Siri

Journal of Integrative Medicine · 2024-11 · 22 (6) · 645-651

DOI: 10.1016/j.joim.2024.08.006 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Integrative Medicine, 2024-11. Verfasst von Zhao-Tang Gong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China; Department of Pha…. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Sepsis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The objective of this study was to investigate the clinical efficacy and safety of treating sepsis patients with Xuebijing injection (XBJI). METHODS: We conducted a retrospective analysis of 418 patients who experienced severe infections and were treated with XBJI from June 2018 to June 2021. Propensity score matching was used to match the patient cases. The study population included 209 pairs of cases (418 individuals), and the analysis included data from before and after a 14-day course of treatment with carbapenem alone, or carbapenem with XBJI. RESULTS: There were no significant differences in the 14-day mortality or length of hospital stay (P > 0.05) between the two groups. The combined treatment group had more patients with C-reactive protein that returned to normal levels (compared to baseline) than the non-combined treatment group (14.4% vs 8.1%; odds ratio [OR]: 0.528; 95% confidence interval [CI]: 0.282-0.991; P = 0.026). Similarly, the combined treatment group had higher procalcitonin attainment rate (55.0% vs 39.7%; OR: 0.513; 95% CI: 0.346-0.759; P = 0.001) than the non-combined treatment group. Further, more patients in the combined treatment group achieved normal creatinine levels than in the non-combined treatment group (64.1% vs 54.1%; OR: 0.659; 95% CI: 0.445-0.975; P = 0.037). CONCLUSION: The combination of XBJI with carbapenem did not reduce the 14-day mortality rate of patients with severe infection, but it was able to reduce the level of inflammatory factors in patients with sepsis, and had a protective effect on liver and kidney function. Please cite this article as: Gong ZT, Yang HX, Zhu BB, Liu HH, Siri GL. Clinical efficacy of Xuebijing injection for the treatment of sepsis: A retrospective cohort study. J Integr Med. 2024; 22(6): 645-651.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalSepsisHumansRetrospective StudiesMaleFemaleMiddle AgedAgedTreatment OutcomeAnti-Bacterial AgentsC-Reactive ProteinCarbapenemsLength of StayInjectionsAdultDrug Therapy, CombinationProcalcitonin

Stichwörter der Autor:innen

Inflammatory factorsMortalitySepsisSeptic shockXuebijing injection

Substanzen

Drugs, Chinese HerbalXuebijingAnti-Bacterial AgentsC-Reactive ProteinCarbapenemsProcalcitonin

Autor:innen und Institutionen

  • Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China; Department of Pharmacy, Inner Mongolia Medical University, Hohhot 010110, Inner Mongoli…
  • Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China.
  • Department of Pharmacy, Peking University Cancer Hospital (Inner Mongolia Campus)/Affiliated Cancer Hospital of Inner Mongolia Medical University, Hohhot 010020, Inner Mongolia Autonomous Region, China.
  • Department of Pharmacy, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100010, China.
  • Department of Pharmacy, Inner Mongolia Autonomous Region People's Hospital, Hohhot 010017, Inner Mongolia Autonomous Region, China; Inner Mongolia Academy of Medical Sciences, Hohhot 010017, Inner Mongolia Autonomous Re…

Zitieren

APA

Gong, Z. T., Yang, H. X., Zhu, B. B., Liu, H. H., & Siri, G. (2024). Clinical efficacy of Xuebijing injection for the treatment of sepsis: A retrospective cohort study. Journal of Integrative Medicine, 22(6), 645-651. https://doi.org/10.1016/j.joim.2024.08.006

Vancouver

Gong ZT, Yang HX, Zhu BB, Liu HH, Siri G. Clinical efficacy of Xuebijing injection for the treatment of sepsis: A retrospective cohort study. Journal of Integrative Medicine. 2024;22(6):645-651. doi:10.1016/j.joim.2024.08.006

BibTeX
@article{Gong2024,
  author = {Gong, Zhao-Tang and Yang, Hong-Xin and Zhu, Ben-Ben and Liu, Huan-Huan and Siri, Guleng},
  title = {Clinical efficacy of Xuebijing injection for the treatment of sepsis: A retrospective cohort study},
  journal = {Journal of Integrative Medicine},
  year = {2024},
  volume = {22},
  number = {6},
  pages = {645--651},
  doi = {10.1016/j.joim.2024.08.006}
}
Kostenlos starten →